The changing roles of steroid nuclear receptors with prostate cancer progression

Rosalinda M. Savoy, Paramita M Ghosh

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Estrogens were once used for the treatment of prostate cancer (PC). They may still be used in various parts of the world to that effect. Recent developments in the understanding of a role for estrogen receptor b (ERb) in the development and progression of this disease resurrect the discussion on the intertwined roles of ER b and the androgen receptor (AR) in promoting PC. A new article by Zellweger et al. in Endocrine-Related Cancer investigates the expression and assesses the activity of ERa and ERb as well as the AR, in addition to a phosphorylated form of AR in hormone-naïve and castration-resistant PC.

Original languageEnglish (US)
JournalEndocrine-Related Cancer
Issue number4
StatePublished - Aug 2013


  • Androgen receptor
  • Estrogen receptor β
  • Hormone-naïve
  • Prostate cancer
  • Serine 210 phosphorylation

ASJC Scopus subject areas

  • Endocrinology
  • Oncology
  • Cancer Research
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'The changing roles of steroid nuclear receptors with prostate cancer progression'. Together they form a unique fingerprint.

Cite this